Anzeige
Mehr »
Montag, 13.04.2026 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40S1S | ISIN: US1311001093 | Ticker-Symbol:
NASDAQ
13.04.26 | 20:50
1,120 US-Dollar
-8,20 % -0,100
Branche
Logistik/Transport
Aktienmarkt
Sonstige
1-Jahres-Chart
CALLAN JMB INC Chart 1 Jahr
5-Tage-Chart
CALLAN JMB INC 5-Tage-Chart

Aktuelle News zur CALLAN JMB Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrCALLAN JMB INC. - 8-K, Current Report-
DiCallan JMB Inc.: Callan JMB Successfully Deploys Rapid Redistribution of Critical Pharmaceuticals to Combat Localized Disease Outbreaks for Longstanding Customer723Reverse Distribution Coordination Delivered Necessary Medical Supplies to Requesting Jurisdictions through its Established Emergency Preparedness Network SPRING BRANCH, Texas, April 07, 2026 (GLOBE...
► Artikel lesen
CALLAN JMB Aktie jetzt für 0€ handeln
31.03.Callan JMB Inc. GAAP EPS of -$1.82, revenue of $5.72M4
31.03.CALLAN JMB INC. - 10-K, Annual Report-
31.03.CALLAN JMB INC. - 8-K, Current Report-
27.03.Callan JMB to oversee manufacturing for JKB-122 immune platform1
27.03.Callan JMB Inc.: Callan JMB Supports U.S. Scale-Up of Multi-Indication Immune Platform with Phase 2b/3 Advancement4
12.03.CALLAN JMB INC. - 8-K, Current Report2
11.03.Callan JMB to oversee manufacturing for Long COVID drug trial4
11.03.Callan JMB Inc. to Oversee Manufacturing and Quality Control of Attune Biotech's IND Clinical Trials for lodonal in the Treatment of Long COVID2
15.01.Callan JMB Shares Soar 240% On Strategic Biotech Oversight Deal2
15.01.Callan JMB signs strategic agreement with Attune Biotech2
15.01.Callan JMB Inc.: Callan JMB Signs Manufacturing Oversight, Federal Deployment, and Commercialization Agreement of Multi-Asset Therapeutic Pipeline with Attune for Approximately $50 to $75 Million in Total Revenue4
12.01.Callan JMB Inc. Announces Major Strategic Pivot to Cold-Chain Infrastructure for the $100 Billion GLP-1 Pharmaceutical Market; Initiates Retrofitting of Texas cGMP Facility611GALVESTON, TX / ACCESS Newswire / January 12, 2026 / Callan JMB Inc. (NASDAQ:CJMB), a premier provider of vertically integrated temperature-controlled logistics and specialized life sciences fulfillment...
► Artikel lesen
31.12.25CALLAN JMB INC. - 8-K, Current Report1
08.12.25Callan JMB ändert Richtlinie für Insiderhandel und verkürzt die Sperrfrist7
05.12.25CALLAN JMB INC. - 8-K, Current Report1
14.11.25Callan JMB Inc. GAAP EPS of -$0.61, revenue of $1.44M3
14.11.25Callan JMB Inc.: Callan JMB Announces Third Quarter 2025 Financial Results and Provides Business Update1.108Expanded the Company's compliance-driven logistics platform into the food sampling industryEntered agreement to install oral drug delivery equipment at Texas facility Established a subsidiary in India...
► Artikel lesen
13.11.25Callan JMB enters agreement to host oral drug delivery manufacturing2
Weiter >>
26 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1